Revenue grew 26.38% year-over-year to ¥878.27 million, with net profit up 2.12% to ¥165.24 million. Gross margin declined due to higher instrument sales, while R&D investment and international reagent sales increased.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.